½ÃÀ庸°í¼­
»óǰÄÚµå
1459640

¼¼°èÀÇ È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç° ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2024-2032³â)

Global Sodium Hyaluronate-based Products Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç° ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 107¾ï 2,000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â 216¾ï 5,000¸¸ ´Þ·¯¿¡ À°¹ÚÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2032³â°£ ¿¬Æò±Õ 8.13%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç°Àº ÇǺΠº¸½À°ú °üÀý À±È°À» À§ÇØ È÷¾Ë·ç·Ð»êÀÇ ÀÌÁ¡À» Ȱ¿ëÇÕ´Ï´Ù. ÀÌ Á¦Ç°µéÀº ÇǺΠº¸½À ¹× °üÀý Áõ»ó ¿ÏÈ­¸¦ ¸ñÀûÀ¸·Î ÇǺΠ°ü¸® ¹× ÀÇ·á¿ëÀ¸·Î ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç° ½ÃÀåÀº ÇǺΠ°ü¸® ¹× °üÀý °Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ Ȱ±â¸¦ ¶ì°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â õ¿¬ À¯·¡ ¹°ÁúÀÎ È÷¾Ë·ç·Ð»ê ³ªÆ®·ýÀÇ º¸½À ¹× À±È° È¿°ú¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁø °ÍÀÔ´Ï´Ù. ½ºÅ²ÄÉ¾î ¾÷°è´Â Àþ°í °Ç°­ÇÑ ÇǺθ¦ ¿øÇÏ´Â ¼ÒºñÀÚÀÇ ¿ä±¸¿¡ ºÎÀÀÇÏ¿© º¸½ÀÁ¦, ¼¼·³, ÆäÀÌ¼È ÇÊ·¯ µî ´Ù¾çÇÑ Á¦Ç°¿¡ È÷¾Ë·ç·Ð»ê ³ªÆ®·ýÀ» ÷°¡ÇÏ´Â »ç·Ê°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ºÎ¹®¿¡¼­ È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç°Àº °üÀý °Ç°­¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ¸ç °ñ°üÀý¿°°ú °°Àº Áõ»óÀ» ¿ÏÈ­ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ¶ÇÇÑ ÃßÃâ ¹× »ý»ê ¹æ¹ýÀÇ ¹ßÀü¿¡ ¿µÇâÀ» ¹Þ¾Æ ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëÇÒ ¼ö ÀÖ´Â °íǰÁúÀÇ »ýü ÀÌ¿ë·üÀÌ ³ôÀº È÷¾Ë·ç·Ð»ê ³ªÆ®·ýÀ» °ø±ÞÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

¶ÇÇÑ, ¼ÒºñÀÚµéÀÌ ÇǺΠ°ü¸®¿Í °üÀý °Ç°­ ºÐ¾ß¿¡¼­ ¾ÈÀüÇϰí È¿°úÀûÀÎ ´ë¾ÈÀ» ã´Â °¡¿îµ¥, È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç°Àº õ¿¬ À¯·¡¿Í ÃÖ¼ÒÇÑÀÇ ºÎÀÛ¿ëÀ¸·Î ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. ½ºÅ²ÄÉ¾î ºê·£µå, Á¦¾àȸ»ç, ¿¬±¸±â°üÀÇ Çù¾÷Àº Á¦Ç° Çõ½Å ½ÃÀå È®´ë¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀüüÀûÀÎ °Ç°­ ÁöÇâ Áõ°¡¿Í ¹Ì¿ë ¹× ÀÇ·á »ê¾÷ÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀå °æÀï, Á¦Ç° Ç¥ÁØÈ­, °¡°Ý ¾Ð·ÂÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â È÷¾Ë·ç ·Ð»ê ³ªÆ®·ý ±â¹Ý Á¦Ç° ¼¼°è ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÕ´Ï´Ù. È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç° »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ ¿¬±¸¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» ¼³¸íÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç° ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡ ¹× Áö¿ª ¼öÁØÀÇ ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·«°¡°¡ °¢ Á¦Ç° ¶Ç´Â ¼­ºñ½ºÀÇ ´ë»ó °í°´À» ½Äº°ÇÒ ¶§ ÇâÈÄ ºñÁî´Ï½º ±âȸ¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

À¯Çüº°

  • ±¹¼Ò
  • ÁÖ»ç
  • ±âŸ

¿ëµµº°

  • ÀǾàǰ(¾È°ú, Á¤Çü¿Ü°ú, ºñ´¢±â°ú, ±âŸ)
  • È­Àåǰ

Áö¿ªº° ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç° ½ÃÀåÀÇ ÇöÀç¿Í ¹Ì·¡ ¼ö¿ä¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ´Â Áö¿ªº° Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, ÀÌ º¸°í¼­´Â ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ÀÀ¿ë ºÐ¾ß¿¡ ´ëÇÑ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

¿äûÀÌ ÀÖÀ¸½Ã¸é ´ç»ç·Î ¿¬¶ôÁֽʽÿÀ. ´ç»çÀÇ Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç° - »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • PorterÀÇ Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç° ½ÃÀå ºÐ¼® : À¯Çüº°

  • À¯Çüº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • À¯Çüº° ºÐ¼®
  • ±¹¼Ò
  • ÁÖ»ç
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç° ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ¿ëµµº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ¿ëµµº° ºÐ¼®
  • ÀǾàǰ(¾È°ú, Á¤Çü¿Ü°ú, ºñ´¢±â°ú, ±âŸ)
  • È­Àåǰ

Á¦7Àå ¼¼°èÀÇ È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç° ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ¿ª»çÀû ÃßÀÌ¿Í ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç° ±â¾÷ °æÀï ±¸µµ

  • È÷¾Ë·ç·Ð»ê³ªÆ®·ý Á¦Ç° ½ÃÀå °æÀï
  • Á¦ÈÞ/Çù·Â/ÇùÁ¤
  • ÀμöÇÕº´(M&A)
  • ½ÅÁ¦Ç° Ãâ½Ã
  • ±âŸ °³¹ß

Á¦9Àå ±â¾÷ °³¿ä

  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Allergan Inc.(AbbVie Inc.ÀϺÎ)
  • Galderma S.A.
  • Bohus BioTech AB
  • LG Chem Ltd.
  • Syner-Med(Pharmaceutical Products) Ltd.
  • Anika Therpeutics Inc.
  • Cadila Pharmaceuticals Ltd.
  • Ferring Pharmaceuticals B.V.
  • Fidia Farmaceutici S.p.A.
LSH 24.04.18

The global demand for Sodium Hyaluronate-based Products Market is presumed to reach the market size of nearly USD 21.65 Billion by 2032 from USD 10.72 Billion in 2023 with a CAGR of 8.13% under the study period 2024 - 2032.

Sodium hyaluronate-based products leverage the benefits of hyaluronic acid for skin hydration and joint lubrication. These products are widely used in skin care and medical applications to moisturize the skin or relieve joint conditions.

MARKET DYNAMICS

The Sodium hyaluronate-based products market is flourishing due to factors responding to the growing demand for skincare and joint health solutions. One of the primary drivers is increasing consumer awareness about the benefits of sodium hyaluronate, a naturally occurring substance known for its hydrating and lubricating properties. The skincare industry has witnessed a surge in incorporating sodium hyaluronate in various products, such as moisturizers, serums, and facial fillers, catering to the desire for youthful and healthy-looking skin. In medicine, sodium hyaluronate-based products play a crucial role in joint health, relieving conditions like osteoarthritis. The market is also influenced by advancements in extraction and production methods, ensuring the availability of high-quality and bioavailable sodium hyaluronate for diverse applications.

Additionally, as consumers seek safe and effective alternatives in skincare and joint health, sodium hyaluronate-based products gain prominence for their natural origin and minimal side effects. Collaborations between skincare brands, pharmaceutical companies, and research institutions further contribute to product innovation market expansion. With a rising emphasis on holistic well-being and the continuous evolution of the beauty and healthcare industries, the market is poised for sustained growth. However, market competition, product standardization, and pricing pressures likely hamper market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of sodium hyaluronate-based products. The growth and trends of sodium hyaluronate-based products industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the sodium hyaluronate-based products market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Topical
  • Injectable
  • Others

By Application

  • Pharmaceuticals (Ophthalmology, Orthopedic, Urology, Others)
  • Cosmetics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Sodium Hyaluronate-based Products market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Sodium Hyaluronate-based Products market include Allergan Inc.(a part of AbbVie, Inc.), Galderma S.A., Bohus BioTech AB, LG Chem Ltd., Syner-Med (Pharmaceutical Products) Ltd., Anika Therpeutics Inc., Cadila Pharmaceuticals Ltd., Ferring Pharmaceuticals B.V., Fidia Farmaceutici S.p.A.. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . SODIUM HYALURONATE-BASED PRODUCTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL SODIUM HYALURONATE-BASED PRODUCTS MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Topical Historic and Forecast Sales by Regions
  • 5.5 Injectable Historic and Forecast Sales by Regions
  • 5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL SODIUM HYALURONATE-BASED PRODUCTS MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Pharmaceuticals (Ophthalmology, Orthopedic, Urology, Others) Historic and Forecast Sales by Regions
  • 6.5 Cosmetics Historic and Forecast Sales by Regions

7 . GLOBAL SODIUM HYALURONATE-BASED PRODUCTS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE SODIUM HYALURONATE-BASED PRODUCTS COMPANIES

  • 8.1. Sodium Hyaluronate-Based Products Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF SODIUM HYALURONATE-BASED PRODUCTS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Allergan Inc.(a part of AbbVie Inc.)
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Galderma S.A.
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Bohus BioTech AB
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. LG Chem Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Syner-Med (Pharmaceutical Products) Ltd.
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Anika Therpeutics Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Cadila Pharmaceuticals Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Ferring Pharmaceuticals B.V.
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Fidia Farmaceutici S.p.A.
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦